• Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
  
• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (from parent cell line).
  

PubMed=8077054; DOI=10.1002/ijc.2910580512
Xu B.H., Gupta V., Singh S.V.
Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
Int. J. Cancer 58:686-692(1994)

PubMed=7729958; DOI=10.1002/ijc.2910610326
Singh S.V., Xu B.H., Jani J.P., Emerson E.O., Backes M.G., Rihn C., Scalamogna D., Stemmler N., Specht S., Blanock K., Katoh A., Gupta V.
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Int. J. Cancer 61:431-436(1995)